Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-6
Closed -$2K 1934
2018
Q1
$2K Hold
6
﹤0.01% 2581
2017
Q4
$2K Hold
6
﹤0.01% 2581
2017
Q3
$2K Hold
6
﹤0.01% 2560
2017
Q2
$4K Hold
6
﹤0.01% 2324
2017
Q1
$4K Sell
6
-5,506
-100% -$5.58M ﹤0.01% 2324
2016
Q4
$5.96M Sell
5,512
-19,221
-78% -$24.5M 0.03% 445
2016
Q3
$37.1M Sell
24,733
-9,275
-27% -$11.6M 0.21% 144
2016
Q2
$40M Buy
34,008
+1,744
+5% +$1.91M 0.24% 117
2016
Q1
$27M Buy
32,264
+2,642
+9% +$2.45M 0.17% 198
2015
Q4
$32.2M Buy
29,622
+17,107
+137% +$19.2M 0.22% 131
2015
Q3
$14.2M Sell
12,515
-10,868
-46% -$18.6M 0.1% 296
2015
Q2
$30.1M Buy
23,383
+2,042
+10% +$2.8M 0.22% 143
2015
Q1
$28.7M Buy
21,341
+3,383
+19% +$4.17M 0.21% 139
2014
Q4
$17.4M Buy
17,958
+1,238
+7% +$1.13M 0.14% 239
2014
Q3
$15.2M Buy
+16,720
New +$13.4M 0.13% 237

Other funds holding ASRT

Glenmede Trust's ASRT Position: Q2 2018 in Review

Glenmede Trust sold out of Assertio (ASRT) in Q2 2018, closing a stake of 6 shares — an estimated $2K sold.

Glenmede Trust first reported a position in ASRT in Q3 2014 and held it in 15 quarters. The position peaked at $40M in Q2 2016. 171 funds tracked by Wall St. Rank hold ASRT as of Q2 2018.

  • Glenmede Trust reported no remaining Assertio position as of Q2 2018 after selling out during the quarter.
  • Glenmede Trust sold 6 Assertio shares in Q2 2018, an estimated $2K.
  • Glenmede Trust first reported a position in Assertio in Q3 2014 and held it in 15 quarters.
  • Glenmede Trust's Assertio position peaked at $40M in Q2 2016.
  • 171 funds tracked by Wall St. Rank held Assertio as of Q2 2018.

Based on Glenmede Trust's 13F filing for Q2 2018, filed 15 Aug 2018.